Thanks, I was aware of the upcoming presentations, and early June certainly looks busy. What I don't know is what technical conference companies really look forward to presenting at, like ASCO for cancer, as well as a few others.
Is the conference in Berlin held at that sort of esteem? The others, as I see it, are investors conferences which certainly could generate interest, but wouldn't be where new data was revealed for peer review that could excite investors once revealed.
We have many opportunities which could lead to either partnerships, or even substantial income before FDA approval in the case of handling radiation, should the DOD act, I just don't know that such actions can be anticipated.
Gary
News 
Market Data 
Discover 
AI
